Pulmonary & Critical Care Division Newsletter

March 2026

Welcome to the March 2026 edition of our division newsletter. Below you’ll find updates from each department including research highlights, clinical news, social updates, and more.

ICU

Clinical Updates



MICU Infection Rates Improve in 2025


Congratulations to the entire MICU team for the outstanding work in reducing infection rates in 2025. Our rates of CLABSI and C. difficile have both improved compared with prior years, reflecting the consistent attention to infection prevention practices across the unit. This progress represents the collective effort of physicians, nurses, respiratory therapists, and the entire ICU staff.




MICU Practice Updates


Updates to 4-Factor Prothrombin Complex Concentrate Ordering (see email).

Femoral Venous Access: Remember to scrub with chlorhexidine with friction for 2 minutes and allow to dry for 2 minutes for femoral lines.

Antibiotic order question in EPIC (system-wide): There is now a question, "Is Infectious Disease consulted?"

For HFH Detroit, you DO NOT need an ID consult for Cefepime — you can answer "No" for Cefepime.

Other hospitals (Legacy Ascension) still require an ID consult for some cephalosporins.

Let's remember to keep our infectious disease friends in the loop! They want to help!

New C. auris hard stop in EPIC: Please see email for details.


Inside the Pulmonary Division

Pulmonary Function Lab Adopts Z-Score Reporting for PFT Interpretation

The Pulmonary Function Testing Laboratory has implemented an important update to its reporting system with the transition to z-score–based interpretation of pulmonary function tests. Under the leadership of Michael Lazar, M.D., Director of the PFT Lab, this change reflects the growing use of z-scores in pulmonary medicine and provides a more precise way to interpret lung function data.

Traditional PFT interpretation relied largely on percent-predicted values. While familiar, these thresholds can oversimplify physiologic variation across age and body size. Z-scores instead compare a patient’s result to a population distribution and express how far the value deviates from the expected mean. This approach allows clinicians to better understand whether a measurement truly falls outside the normal range.

“Many of our pulmonologists have used z-scores in prior training or at other institutions, but for some who have interpreted PFTs with percent predicted for many years, there is naturally a short adjustment period as everyone gets used to the new format.”
— Michael Lazar, M.D.
Many pulmonologists in the group are already familiar with this framework from prior training or previous institutions where z-scores have been used for years. For others who have interpreted PFTs using percent predicted for most of their careers, the transition has required a brief adjustment period. As expected with any change in reporting standards, there have been some growing pains, but most clinicians are quickly becoming comfortable with the new format as they gain experience reviewing studies.

Dr. Lazar notes that the transition represents an exciting step forward in improving the accuracy and consistency of PFT interpretation across the system. Along with the transition to z-scores, the PFT software has also been updated to improve readability and workflow for interpreting physicians. Interpretation statements are now spaced to clearly separate spirometry, lung volumes, and DLCO into distinct paragraphs. This allows clinicians to review each section individually and make adjustments as needed before finalizing the interpretation.

A new interpretation template, “HENRY FORD INTERPRETATION 2026-01-09,” is now available within the SentrySuite system. Physicians can insert this template by selecting the graduation-cap icon within the physician box. In most cases, PFT technicians will continue to insert the interpretation prior to physician review, though interpreters can add it themselves when needed.

The previous interpretation set will remain on the server for several months during the transition period. Physicians are encouraged to report any issues or suggested improvements as the lab continues refining this updated system.

Fellowship

Fellows’ Journal Club Highlights


Pulmonary fellows continue to lead Journal Club discussions on important studies relevant to pulmonary medicine. These sessions focus not only on the clinical questions addressed by the research, but also on examining the study design and methodology (both strong and problematic), so fellows develop the skills needed to critically evaluate the medical literature. Recent highlights are listed below.

COPD



  • 2025-12-22Occupational Exposure and Clinical Outcomes — (Nader)

  • 2025-08-25Major Adverse Cardiovascular Events After Hospitalization — (Hanalla)

  • 2025-08-11Long-acting Bronchodilators in Hospitalized Patients — (Hanalla)

  • 2025-05-12Eosinophil-guided Steroid Therapy (CORTICO-COP) — (Zeid)

  • 2025-04-28Mucus Plugs and Mortality — (Khalifeh)

  • 2025-04-14Ensifentrine for Treatment — (Khalifeh)


Interstitial Lung Disease



  • 2026-02-16ACEI Use and Mortality in IPF — (Rani)

  • 2026-01-12Family History and Fibrosis Outcomes — (Nader)

  • 2025-12-15Nintedanib in Progressive Fibrosing Disease — (Zero)

  • 2025-06-09Cyclophosphamide in Acute Exacerbation — (Jurayj)




Pulmonary Vascular Disease



  • 2025-10-13Recurrent VTE Risk and Bleeding in Subsegmental PE — (Parsons)

  • 2025-09-22PEERLESS Trial: TPA vs Thrombectomy — (Santhi)

  • 2025-09-08Sotatercept in Pulmonary Arterial Hypertension — (Santhi)


Infections & Other Topics



  • 2025-11-17Inhaled Tobramycin for Pseudomonas Bronchiectasis — (Foy)

  • 2025-10-27Intrapleural TPA/DNase in Pleural Infection — (Foy)

  • 2025-07-14Anaerobic Coverage in Aspiration Pneumonia — (Zahedi)

  • 2025-06-23Maternal Asthma and Perinatal Mortality — (Jurayj)

  • 2025-11-10Prednisone vs Methotrexate in Sarcoidosis — (Foy)



Administrative

Highlights

The 2026 Mosaic CIN Annual Meeting was watched by many either in person, or if unable to attend, by video. Please remember to fill out the survey!